Turn Therapeutics Inc. TTRX
- GX-03 — Moderate-to-Severe Eczema Phase 2
- GX-03 — Atopic Dermatitis Phase 2
IL-4 (2 companies · 3 programs)
Companies with an active program directed at IL-4.
Medicenna Therapeutics Corp. MDNAF
- bizaxofusp — Recurrent Glioblastoma Phase 3